SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice

Inhibition of the sodium-glucose co-transporter type 2 (SGLT2) has received growing acceptance as a novel, safe and effective means to improve glycemic control in patients with type 2 diabetes. Inhibition of SGLT2 lowers the renal glucose threshold and reduces plasma glucose by promoting glucose exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurczak, Michael J., Saini, Saumya, Ioja, Simona, Costa, Diana K., Udeh, Nnamdi, Zhao, Xiaojian, Whaley, Jean M., Kibbey, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284495/
https://www.ncbi.nlm.nih.gov/pubmed/30118626
http://dx.doi.org/10.1080/19382014.2018.1503027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284495/
https://www.ncbi.nlm.nih.gov/pubmed/30118626
http://dx.doi.org/10.1080/19382014.2018.1503027

Ejemplares similares